Spire Healthcare Group PLC

Major Shareholding Notification • Feb 16, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0755X

Spire Healthcare Group PLC

16 February 2017

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			Spire Healthcare Group plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached				X
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		The Goldman Sachs Group, Inc.
4. Full name of shareholder(s) (if different from 3.):iv		Goldman Sachs International Goldman, Sachs & Co. GS Investment Strategies, LLC
5. Date of the transaction and date on which the threshold is crossed or reached: v		13 February 2017
6. Date on which issuer notified:		15 February 2017
7. Threshold(s) that is/are crossed or reached: vi, vii		Above 3%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of

shares

if possible using

the ISIN CODE

Situation previous

to the triggering

transaction

Resulting situation after the triggering transaction

Number

of

Shares

Number

of

Voting

Rights

Number

of shares

Number of voting

rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00BNLPYF73

Below 3%

Below 3%

6,946,370

1.732%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial

instrument

Expiration

date xiii

Exercise/

Conversion Period xiv

Number of voting

rights that may be

acquired if the

instrument is

exercised/ converted.

% of voting

rights

Stock Loan (Physical)

Open

5,097,404

1.271%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument	Exercise price	Expiration date	Exercise/ Conversion period	Number of voting rights instrument refers to	% of voting rights xix, xx
Nominal	Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

12,043,774

3.003%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
-----------------The Goldman Sachs Group, Inc.; 12,043,774 shares; 3.003% Goldman Sachs (UK) L.L.C. (Controlled by The Goldman Sachs Group, Inc.) Goldman Sachs Group UK Limited (Controlled by Goldman Sachs (UK) L.L.C.) Goldman Sachs International (Controlled by Goldman Sachs Group UK Limited) The Goldman, Sachs & Co. L.L.C. (Controlled by The Goldman Sachs Group, Inc.) Goldman, Sachs & Co. (Controlled by The Goldman, Sachs & Co. L.L.C.) GSAM Holdings LLC (Controlled by The Goldman Sachs Group, Inc.) GS Investment Strategies, LLC (Controlled by GSAM Holdings LLC)
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	Please note, total amount of voting rights have been rounded to 3 decimal places therefore there is a possibility of a rounding error. General email contact: shareholderdisclosures@gs.com
14. Contact name:	Joanna Foley
15. Contact telephone number:	+44 207 051 9996

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUNVKRBNAUARR